Zhangzhou Pientzehuang Pharmaceutical Co Ltd Total Assets
Zhangzhou Pientzehuang Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) holds total assets worth CN¥18.38 Billion CNY (≈ $2.69 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Zhangzhou Pientzehuang Pharmaceutical Co for the company's overall valuation and market capitalisation.
Total Assets of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
Total assets of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025. This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Zhangzhou Pientzehuang Pharmaceutical Co for real-time trading data and today's change.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Asset Composition Analysis
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Total Assets Breakdown (December 2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd total assets breakdown as of December 2025. Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total assets of CN¥18.38 Billion consist of 60.8% current assets and 39.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.2% |
| Accounts Receivable | CN¥753.17 Million | 4.3% |
| Inventory | CN¥6.68 Billion | 38.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥267.49 Million | 1.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 600436 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhangzhou Pientzehuang Pharmaceutical Co Ltd's current assets represent 60.8% of total assets in 2025, a decrease from 76.0% in 2000.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, up from 2.3% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 38.0% of total assets.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
SW:NOVN
|
Switzerland | CHF118.89 Billion |
|
AstraZeneca PLC
NASDAQ:AZN
|
USA | $114.02 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$201.13 Billion |
|
Novartis AG
MX:NVSN
|
Mexico | MX$118.53 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $32.09 Billion |
|
Organon & Co
NYSE:OGN
|
USA | $13.18 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥12.85 Billion |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771
|
China | CN¥2.55 Billion |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.02 | 5.24 | 4.97 |
| Quick Ratio | 2.26 | 3.11 | 3.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥9.15 Billion | CN¥9.85 Billion | CN¥7.21 Billion |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.51 |
| Latest Market Cap to Assets Ratio | 0.68 |
| Asset Growth Rate (YoY) | 0.1% |
| Total Assets | CN¥17.56 Billion |
| Market Capitalization | $12.01 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhangzhou Pientzehuang Pharmaceutical Co Ltd's assets below their book value (0.68x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhangzhou Pientzehuang Pharmaceutical Co Ltd's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual total assets of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥17.56 Billion ≈ $2.57 Billion |
+0.12% |
| 2024-12-31 | CN¥17.54 Billion ≈ $2.57 Billion |
+2.69% |
| 2023-12-31 | CN¥17.08 Billion ≈ $2.50 Billion |
+16.96% |
| 2022-12-31 | CN¥14.60 Billion ≈ $2.14 Billion |
+16.87% |
| 2021-12-31 | CN¥12.50 Billion ≈ $1.83 Billion |
+22.44% |
| 2020-12-31 | CN¥10.21 Billion ≈ $1.49 Billion |
+15.83% |
| 2019-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+32.34% |
| 2018-12-31 | CN¥6.66 Billion ≈ $974.24 Million |
+17.87% |
| 2017-12-31 | CN¥5.65 Billion ≈ $826.52 Million |
+12.12% |
| 2016-12-31 | CN¥5.04 Billion ≈ $737.19 Million |
+24.24% |
| 2015-12-31 | CN¥4.05 Billion ≈ $593.36 Million |
+11.10% |
| 2014-12-31 | CN¥3.65 Billion ≈ $534.06 Million |
+11.98% |
| 2013-12-31 | CN¥3.26 Billion ≈ $476.94 Million |
+46.11% |
| 2012-12-31 | CN¥2.23 Billion ≈ $326.43 Million |
+42.21% |
| 2011-12-31 | CN¥1.57 Billion ≈ $229.55 Million |
+8.42% |
| 2010-12-31 | CN¥1.45 Billion ≈ $211.72 Million |
+12.63% |
| 2009-12-31 | CN¥1.28 Billion ≈ $187.97 Million |
+19.99% |
| 2008-12-31 | CN¥1.07 Billion ≈ $156.65 Million |
+10.27% |
| 2007-12-31 | CN¥970.88 Million ≈ $142.07 Million |
+32.88% |
| 2006-12-31 | CN¥730.62 Million ≈ $106.91 Million |
+5.33% |
| 2005-12-31 | CN¥693.63 Million ≈ $101.50 Million |
+24.13% |
| 2004-12-31 | CN¥558.77 Million ≈ $81.77 Million |
-6.09% |
| 2003-12-31 | CN¥594.99 Million ≈ $87.07 Million |
+82.63% |
| 2002-12-31 | CN¥325.79 Million ≈ $47.67 Million |
+20.50% |
| 2001-12-31 | CN¥270.36 Million ≈ $39.56 Million |
+4.52% |
| 2000-12-31 | CN¥258.68 Million ≈ $37.85 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemic… Read more